Research Daily Summary
Research Daily Summary: What Happened on October 9, 2026
Placental model tracks cadmium exposure and tissue dysfunction
A review found code-sharing statements in 12.2% of clinical prediction model papers and uneven reproducibility features across repositories.
Today in brief
A microfluidic system built with human placental cells modeled barrier responses and tissue impairment after cadmium exposure.1 Researchers also identified transporter proteins that may protect against toxicity and tested the system’s potential for finding metabolic biomarkers.1
Among 3,967 clinical prediction model papers, 482 included code-sharing statements. Repository documentation and reproducibility features varied considerably.2
A placental model probes cadmium’s effects
Researchers used primary human placental cells in a microfluidic device to model the maternal-fetal interface.1 With cadmium as a model toxicant, the system modeled placental barrier responses and impaired tissue function.1
Trophoblast efflux transporters, which move substances out of cells, may help protect against cadmium-related toxicity.1 The researchers demonstrated the system’s potential for identifying metabolic biomarkers of cadmium-induced placental dysfunction.1
Code-sharing remains uncommon in prediction-model papers
Of 3,967 papers citing TRIPOD or TRIPOD+AI, 482 included statements about sharing code, a review found.2 The review assessed 380 code repositories and found wide variation in documentation and tools for reproducing analyses.2
A README file appeared in 80.5% of repositories, while 37.6% specified software dependencies and 3.9% included tests.2 The authors are developing TRIPOD-Code guidance on code availability and computational reproducibility.2
Also published
- How Routine Lab Markers Can Stand In for Missing Functional Status Data Applied Clinical Trials
- The journal at a glance: Q3 2026 BioTechniques
- What It Takes to Harmonize AI Across Fragmented Oncology Health Systems Applied Clinical Trials